Meeder Asset Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.9K | Buy |
+826
| New | +$11.9K | ﹤0.01% | 585 |
|
2018
Q3 | – | Sell |
-1,495
| Closed | -$5.55K | – | 1715 |
|
2018
Q2 | $5.55K | Buy |
+1,495
| New | +$5.55K | ﹤0.01% | 1254 |
|
2018
Q1 | – | Sell |
-252
| Closed | -$1K | – | 1777 |
|
2017
Q4 | $1K | Sell |
252
-425
| -63% | -$1.69K | ﹤0.01% | 1604 |
|
2017
Q3 | $3K | Buy |
677
+31
| +5% | +$137 | ﹤0.01% | 1390 |
|
2017
Q2 | $2K | Sell |
646
-105
| -14% | -$325 | ﹤0.01% | 1437 |
|
2017
Q1 | $2K | Hold |
751
| – | – | ﹤0.01% | 1418 |
|
2016
Q4 | $2K | Buy |
+751
| New | +$2K | ﹤0.01% | 939 |
|